Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients

por Capdevila, O., Mitjavila, F., Espinosa, G., Caminal-Montero, L., Marín-Ballvè, A., González León, R., Castro, A., Canora, J., Pinilla, B., Fonseca, E., Ruiz-Irastorza, G.
Publicado 2023

Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pn...

por Solanich, X., Antolí, A., Padullés, N., Fanlo-Maresma, M., Iriarte, A., Mitjavila, F., Capdevila, O., Molina, M., Sabater, J., Bas, J., Mensa-Vilaró, A., Niubó, J., Calvo, N., Bolivar, S., Rigo-Bonnin, R., Arregui, L., Tebé, C., Hereu, P., Videla, S., Corbella, X.
Publicado 2021

First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort

por Ruiz-Irastorza, G, Garcia, M, Espinosa, G, Caminal, L, Mitjavila, F, González-León, R, Sopeña, B, Canora, J, Villalba, M V, Rodríguez-Carballeira, M, López-Dupla, J M, Callejas, J L, Castro, A, Tolosa, C, Sánchez-García, M E, Pérez-Conesa, M, Navarrete-Navarrete, N, Rodríguez, A P, Herranz, M T, Pallarés, L
Publicado 2016